Bundy Scanlan Agnes 4

What Happened

• Agnes Bundy, a member of Truist Financial Corporation's Board of Directors, received a grant of 4,027 restricted stock units (RSUs) on February 24, 2026. The Form 4 reports the award as a derivative grant (transaction code A) with a reported price of $0.00 because these are compensation awards rather than an open‑market purchase or sale.

Key Details

• Transaction date and type: 2026-02-24 — Award/Grant (A) of 4,027 RSUs; reported price $0.00.
• Filing date: 2026-02-26 (the Form 4 was filed two days after the grant; no late filing flag is shown).
• Shares owned after transaction: Not disclosed in this filing.
• Principal footnote for this grant (F1): These are restricted stock units under the Truist 2022 Incentive Plan that Bundy elected to defer under the Non‑Employee Directors' Deferred Compensation Plan; payments are made in shares after the director leaves the Board and convert one‑for‑one to common stock.
• Other footnotes noted on the filing: F2 indicates dividend reinvestment has added shares since the last reported transaction; F3 refers to pre‑merger phantom stock units (from SunTrust plans) that convert to the cash equivalent of Truist common stock one‑for‑one upon distribution.

Context

• This was an equity compensation award, not a purchase or sale — common for non‑employee directors and typically part of routine board compensation.
• Because the director elected to defer receipt, the RSUs will convert into shares (or, for certain phantom units, cash equivalent) when the director departs the Board, so there is no immediate change in market trading or liquidity by the insider.